·Confidence 90%
Comparing VanEck Pharma ETF and State Street Biotech ETF
Key takeaways
- VanEck's Pharmaceutical ETF features lower volatility and a 1.9% dividend yield, making it a potentially safer option than State Street's Biotech ETF.
Analysis
VanEck's Pharmaceutical ETF features lower volatility and a 1.9% dividend yield, making it a potentially safer option than State Street's Biotech ETF.
0 likes · 0 dislikes